| Jay S Rechtweg, MD | |
|
990 Stewart Ave, Suite 610, Garden City, NY 11530-4822 | |
| (516) 222-1881 | |
| (516) 222-1885 |
| Full Name | Jay S Rechtweg |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 29 Years |
| Location | 990 Stewart Ave, Garden City, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194724427 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | 217925 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| North Shore University Hospital | Manhasset, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ent And Allergy Associates Llp | 0749193662 | 368 |
News Archive
The recent shootings at the Ft. Hood, Texas army base, allegedly by an army psychiatrist, have placed much-needed focus on mental health care in the army. In an article published in the December issue of the journal CNS Spectrum, renowned psychopharmacology expert Stephen M. Stahl, MD, PhD, calls for increased mental health staffing at Fort Hood and other army bases.
DiscoveryBioMed, Inc. (DBM) today announced that it has been awarded a $200,000 Small Business Innovations Research (SBIR) Phase 1 grant by the National Institutes of Health (NIH) to continue research into the discovery and development of anti-inflammatory phytochemicals to address complications associated with nasal and pulmonary inflammation, dermatitis, and kidney disorders with an inflammatory component.
Americans United for Change, AFSCME, SEIU and MoveOn.org are among the groups targeting GOP lawmakers regarding proposals to cut Medicare. Meanwhile, the U.S. Chamber of Commerce is striking back with ads of its own warning about government-run health care.
Deinove, the world's leading specialist in Deinococcus bacteria for biofuels, green chemistry and antibiotics, today announced that its Deinobiotics project is to receive a total of €1.35 million in grants and loans.
Adimab, Inc., a technology leader in the discovery of fully human antibodies, today announced the initiation of three new independent research collaborations with Eli Lilly, Genentech, and Human Genome Sciences. Over the past 18 months Adimab has established collaborations with several leading Pharmaceutical companies including: Merck, Roche, Novartis, Pfizer, and now Eli Lilly, Genentech, and Human Genome Sciences.
› Verified 7 days ago
| Entity Name | Ent And Allergy Associates Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376598326 PECOS PAC ID: 0749193662 Enrollment ID: O20031107000043 |
News Archive
The recent shootings at the Ft. Hood, Texas army base, allegedly by an army psychiatrist, have placed much-needed focus on mental health care in the army. In an article published in the December issue of the journal CNS Spectrum, renowned psychopharmacology expert Stephen M. Stahl, MD, PhD, calls for increased mental health staffing at Fort Hood and other army bases.
DiscoveryBioMed, Inc. (DBM) today announced that it has been awarded a $200,000 Small Business Innovations Research (SBIR) Phase 1 grant by the National Institutes of Health (NIH) to continue research into the discovery and development of anti-inflammatory phytochemicals to address complications associated with nasal and pulmonary inflammation, dermatitis, and kidney disorders with an inflammatory component.
Americans United for Change, AFSCME, SEIU and MoveOn.org are among the groups targeting GOP lawmakers regarding proposals to cut Medicare. Meanwhile, the U.S. Chamber of Commerce is striking back with ads of its own warning about government-run health care.
Deinove, the world's leading specialist in Deinococcus bacteria for biofuels, green chemistry and antibiotics, today announced that its Deinobiotics project is to receive a total of €1.35 million in grants and loans.
Adimab, Inc., a technology leader in the discovery of fully human antibodies, today announced the initiation of three new independent research collaborations with Eli Lilly, Genentech, and Human Genome Sciences. Over the past 18 months Adimab has established collaborations with several leading Pharmaceutical companies including: Merck, Roche, Novartis, Pfizer, and now Eli Lilly, Genentech, and Human Genome Sciences.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jay S Rechtweg, MD 660 White Plains Rd Fl 4, Tarrytown, NY 10591-5139 Ph: (914) 984-2546 | Jay S Rechtweg, MD 990 Stewart Ave, Suite 610, Garden City, NY 11530-4822 Ph: (516) 222-1881 |
News Archive
The recent shootings at the Ft. Hood, Texas army base, allegedly by an army psychiatrist, have placed much-needed focus on mental health care in the army. In an article published in the December issue of the journal CNS Spectrum, renowned psychopharmacology expert Stephen M. Stahl, MD, PhD, calls for increased mental health staffing at Fort Hood and other army bases.
DiscoveryBioMed, Inc. (DBM) today announced that it has been awarded a $200,000 Small Business Innovations Research (SBIR) Phase 1 grant by the National Institutes of Health (NIH) to continue research into the discovery and development of anti-inflammatory phytochemicals to address complications associated with nasal and pulmonary inflammation, dermatitis, and kidney disorders with an inflammatory component.
Americans United for Change, AFSCME, SEIU and MoveOn.org are among the groups targeting GOP lawmakers regarding proposals to cut Medicare. Meanwhile, the U.S. Chamber of Commerce is striking back with ads of its own warning about government-run health care.
Deinove, the world's leading specialist in Deinococcus bacteria for biofuels, green chemistry and antibiotics, today announced that its Deinobiotics project is to receive a total of €1.35 million in grants and loans.
Adimab, Inc., a technology leader in the discovery of fully human antibodies, today announced the initiation of three new independent research collaborations with Eli Lilly, Genentech, and Human Genome Sciences. Over the past 18 months Adimab has established collaborations with several leading Pharmaceutical companies including: Merck, Roche, Novartis, Pfizer, and now Eli Lilly, Genentech, and Human Genome Sciences.
› Verified 7 days ago
Saul Michael Modlin, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 300 Garden City Plaza, Suite 248, Garden City, NY 11530 Phone: 516-739-0333 Fax: 516-739-0344 | |
Dr. Jeffrey Zauderer, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 990 Stewart Ave, Suite 610, Garden City, NY 11530 Phone: 516-280-1701 Fax: 516-222-1885 | |
Dr. Michael Guy Mendelsohn, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 990 Stewart Ave, Suite 610, Garden City, NY 11530 Phone: 516-222-1881 Fax: 516-222-1885 | |
Dr. Michael A. Gordon, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 990 Stewart Ave, Suite 610, Garden City, NY 11530 Phone: 516-222-1881 Fax: 516-222-1885 | |
Dr. Paul A Bell, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 990 Stewart Avenue, Suite 610, Garden City, NY 11530 Phone: 516-739-3999 Fax: 516-739-1097 | |
Dr. Rajesh S Kakani, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 877 Stewart Ave, Suite 2, Garden City, NY 11530 Phone: 516-222-1105 Fax: 516-222-1161 |